Qiusi Tian

Hanzhong, 723001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Correction: High MCM10 expression mediates TMZ resistance and promotes the progression of glioma.

Correction: High MCM10 expression mediates TMZ resistance and promotes the progression of glioma.

Journal: Cancer chemotherapy and pharmacology

Published: April 11, 2026

Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas.

Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas.

Journal: Journal of the Egyptian National Cancer Institute

Published: February 01, 2026

Nrf2-mediated modulation of ROS homeostasis is associated with NF-κB activation and glioblastoma progression.

Nrf2-mediated modulation of ROS homeostasis is associated with NF-κB activation and glioblastoma progression.

Journal: Bioorganic chemistry

Published: January 04, 2026

Metabolic-transcriptional rewiring by NFE2L2 promotes M2 macrophage polarization and anti-PD-L1 resistance in glioma.

Metabolic-transcriptional rewiring by NFE2L2 promotes M2 macrophage polarization and anti-PD-L1 resistance in glioma.

Journal: Cancer cell international

Published: August 20, 2025

Identification of NFE2L2 as a key biomarker associated with pyroptosis in gliomas through bioinformatics and experiments.

Identification of NFE2L2 as a key biomarker associated with pyroptosis in gliomas through bioinformatics and experiments.

Journal: Scientific reports

Published: July 08, 2025

High MCM10 expression mediates TMZ resistance and promotes the progression of glioma.

High MCM10 expression mediates TMZ resistance and promotes the progression of glioma.

Journal: Cancer chemotherapy and pharmacology

Published: May 27, 2025

Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.

Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.

Journal: CNS neuroscience & therapeutics

Published: February 07, 2025

NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.

NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.

Journal: Technology and health care : official journal of the European Society for Engineering and Medicine

Published: January 22, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026